The usefulness of the platelet function analyser (PFA-100) in screening for underlying bleeding disorders in women with menorrhagia

被引:9
作者
Acharya, S. [1 ]
Barraclough, J. [2 ]
Ibrahim, M. S. [1 ]
Oxby, C. [1 ]
Jones, S. E. [1 ]
Parapia, L. [2 ]
O'Donovan, P. [1 ]
机构
[1] Bradford Royal Infirm, Dept Obstet & Gynaecol, Bradford BD9 6RJ, W Yorkshire, England
[2] Bradford Royal Infirm, Haematol & Haemophila Ctr, Bradford BD9 6RJ, W Yorkshire, England
关键词
menorrhagia; NSAIDs; PFA-100; bleeding disorders;
D O I
10.1080/01443610802141910
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The prevalence of underlying bleeding disorders is common in women with menorrhagia. This was a prospective study to screen for the underlying bleeding disorders in women presenting with menorrhagia by using the PFA-100 and comparing the accuracy of the results with the complete haematological assays. A total of 62 women referred to gynaecology outpatients with a history of heavy, regular periods had blood collected for analysis by the PFA-100 and also a full coagulation profile including von Willebrand factor. PFA-100 analysis suggested platelet defects in 10 (16%) women. This included five (8%) identified with von Willebrand disease, two (3.2%) with storage pool disorders and three (4.8%) without any recognisable platelet or bleeding disorders after a full coagulation profile, including von Willebrand factor, was carried out. PFA-100 results had a sensitivity of 100% and specificity of 94.8% in our study. We conclude that PFA-100 is a quick and reliable method of screening for impaired haemostasis in patients with menorrhagia.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 40 条
[1]  
BRADLOW J, 1992, PATTERNS REFERRAL
[2]   Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems [J].
Cariappa, R ;
Wilhite, TR ;
Parvin, CA ;
Luchtman-Jones, L .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) :474-479
[3]   von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia [J].
Dilley, A ;
Drews, C ;
Miller, C ;
Lally, C ;
Austin, H ;
Ramaswamy, D ;
Lurye, D ;
Evatt, B .
OBSTETRICS AND GYNECOLOGY, 2001, 97 (04) :630-636
[4]   The influence of the haematocrit on primary haemostasis in vitro [J].
Eugster, M ;
Reinhart, WH .
THROMBOSIS AND HAEMOSTASIS, 2005, 94 (06) :1213-1218
[5]   Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease [J].
Favaloro, EJ .
BLOOD REVIEWS, 1999, 13 (04) :185-204
[6]  
Favaloro EJ, 1999, AM J HEMATOL, V62, P165, DOI 10.1002/(SICI)1096-8652(199911)62:3<165::AID-AJH6>3.0.CO
[7]  
2-C
[8]   The utility of the PFA-100 in the identification of von Willebrand disease: A concise review [J].
Favaloro, Emmanuel J. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (05) :537-545
[9]   Alterations in platelet function during the ovarian cycle [J].
Feuring, A ;
Christ, A ;
Roell, A ;
Schueller, P ;
Losel, R ;
Dempfle, CE ;
Schultz, A ;
Wehling, M .
BLOOD COAGULATION & FIBRINOLYSIS, 2002, 13 (05) :443-447
[10]  
Franchini M, 2005, CLIN LAB, V51, P367